Insulet Corp (PODD)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$149.07
Buy
$149.51
$4.27 (+2.95%)
Prices updated at 01 Jun 2026, 17:58 EDT
| Prices minimum 15 mins delay
Prices in USD
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated throu ...
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Sector
Healthcare
Industry
Medical Devices
Chairman
Ms. Elizabeth H. Weatherman
CEO
Ms. Ashley A. McEvoy
Most recent earnings
31 Dec 2025
Fiscal year end
31 Dec 2025
Employees
5,400
Head office
100 Nagog Park
Acton
United States
01720
Key personnel
Owner name | Salary |
|---|---|
Ms. Elizabeth H. Weatherman Chairman of the Board | 0.10m |
Mr. Michael R. Minogue Independent Director | 0.08m |
Mr. Timothy John Scannell Independent Director | 0.18m |
Mr. John W. Kapples Senior Vice President and General Counsel | 0.53m |
Dr. Jessica Hopfield, PhD Independent Director | 0.08m |
Mr. Timothy C. Stonesifer Independent Director | 0.10m |
Mr. Eric Benjamin Executive Vice President and Chief Operating Officer | 0.60m |
Ms. Ashley A. McEvoy Director, President and Chief Executive Officer | 0.73m |
Dr. Wayne A.I. Frederick, M.D. Independent Director | 0.10m |
Dr. Luciana Borio, M.D. Independent Director | 0.09m |
Ms. Flavia H. Pease Executive Vice President and Chief Financial Officer | 0.15m |
Mr. Prem Singh Senior Vice President, Global Operations | 0.44m |
Ms. Lisa Blair Davis Senior Vice President and Chief Human Resources Officer | - |
Mr. Robbie L. Huffines Independent Director | 0.01m |
Mr. Michael H. Panos Executive Vice President and Chief Commercial Officer | - |
Top 5 shareholders
Owner name | No. of shares |
|---|---|
| Vanguard Group Inc | 8,701,472 |
| BlackRock Inc | 6,375,943 |
| FMR Inc | 3,974,712 |
| Fidelity Management and Research Company | 3,974,712 |
| Fidelity Management & Research Company LLC | 3,716,540 |
Director dealings
Date | Action |
|---|---|
| 15 Dec 2025 | - |
| 05 Dec 2025 | - |
| 01 Oct 2025 | - |
| 01 Oct 2025 | - |
| 08 Sep 2025 | - |
| 08 Sep 2025 | - |
| 08 Sep 2025 | - |
| 08 Sep 2025 | - |
| 08 Sep 2025 | - |
| 08 Sep 2025 | - |
| 21 Aug 2025 | - |
| 19 Aug 2025 | - |
| 21 Aug 2025 | - |
| 21 Aug 2025 | - |
| 19 Aug 2025 | - |
| 19 Aug 2025 | - |
| 19 Aug 2025 | - |
| 07 Aug 2025 | - |
| 07 Aug 2025 | - |
| 07 Aug 2025 | - |
Please note that past performance is not a reliable indicator of future returns.
